A Promising Heart Drug Fails, Challenging a Long-Held Theory of Disease (nytimes.com) 4 points by bhouston 1mo ago ↗ HN
[–] bhouston 1mo ago ↗ TL;DR summary:The drug cut inflammation markers (IL-6, CRP) as intended but didn't reduce cardiovascular events or deaths versus placebo. This undermines the "inflammation causes atherosclerosis" thesis.
1 comment
[ 1.7 ms ] story [ 7.7 ms ] threadThe drug cut inflammation markers (IL-6, CRP) as intended but didn't reduce cardiovascular events or deaths versus placebo. This undermines the "inflammation causes atherosclerosis" thesis.